Home > PS Ratio > KIMIA BIOSCIENCES

KIMIA BIOSCIENCES
PS (Price/Sales) Ratio

The Current P/S Ratio of KIMIA BIOSCIENCES is 1.76.

Share Price ₹41.3Apr 04,2025
Market Cap ₹195.5 Cr
Sales-TTM₹111.0 CrTTM-Standalone Results
Price/Sales1.76xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for KIMIA BIOSCIENCES
Please provide your vote to see the results
KIMIA BIOSCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of KIMIA BIOSCIENCES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of KIMIA BIOSCIENCES is calculated as :

Current Market Cap [ ₹195.5 Cr] as on Apr 04,2025

(/) Sales [ ₹111.0 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 1.76x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for KIMIA BIOSCIENCES , the investors are currently willing to pay '1.76 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of KIMIA BIOSCIENCES !

The chart below summarizes the trend in P/S Ratio of KIMIA BIOSCIENCES over the last five years.

Historical PS (Price/Sales) ratio chart of KIMIA BIOSCIENCES


PS Ratio Performance Analysis for KIMIA BIOSCIENCES

- KIMIA BIOSCIENCES 's latest p/e ratio is 1.76x.

- KIMIA BIOSCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.47x.

- KIMIA BIOSCIENCES 's operated at median p/e ratio of 1.35x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KIMIA BIOSCIENCES 's p/e ratio peaked in Mar2024 at 2.51x.

- KIMIA BIOSCIENCES 's p/e ratio hit its five-year low in Mar2020 of 0.87x.


How does KIMIA BIOSCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
KIMIA BIOSCIENCES 111.01.76195.5
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.95410,142.0
DIVIS LABORATORIES LTD9,078.016.06145,762.0
CIPLA LTD26,981.24.24114,322.0
TORRENT PHARMACEUTICALS LTD11,302.09.84111,171.0
DR REDDYS LABORATORIES LTD31,229.32.9792,603.7
MANKIND PHARMA LTD11,641.08.68101,098.0
ZYDUS LIFESCIENCES LTD22,247.43.9287,205.3
LUPIN LTD22,001.64.0989,993.5
AUROBINDO PHARMA LTD30,921.82.0864,167.0
ABBOTT INDIA LTD6,243.29.8961,727.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KIMIA BIOSCIENCES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.76x
Max industry PS 16.06x
Median industry PS 4.24x
Average industry PS 6.50x



You may also like the below Video Courses